Pacira BioSciences, Inc. is a specialty pharmaceutical company focused on developing and commercializing non-opioid pain management and regenerative health solutions. The company's commercial portfolio is anchored by EXPAREL (bupivacaine liposome injectable suspension), a long-acting local analgesic widely used in hospitals and surgery centers for postsurgical pain management. Pacira also markets ZILRETTA, an extended-release intra-articular injection for osteoarthritis knee pain, and iovera°, a handheld device that delivers drug-free pain control using targeted cold temperatures. The company leverages its proprietary DepoFoam multivesicular liposome drug delivery technology to enable the sustained release of medications. By providing effective non-opioid alternatives, Pacira aims to reduce opioid reliance in acute and chronic pain settings while expanding its pipeline with novel therapies, including early-stage gene therapy candidates.
